Skip to main content
Journal cover image

ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Publication ,  Conference
Gandhi, PU; Motiwala, S; Belcher, A; Gaggin, H; Weiner, R; Baggish, A; Fiuzat, M; Rocca, H-PB-L; Januzzi, J
Published in: Journal of the American College of Cardiology
March 2015

Duke Scholars

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2015

Volume

65

Issue

10

Start / End Page

A970 / A970

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gandhi, P. U., Motiwala, S., Belcher, A., Gaggin, H., Weiner, R., Baggish, A., … Januzzi, J. (2015). ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION. In Journal of the American College of Cardiology (Vol. 65, pp. A970–A970). Elsevier BV. https://doi.org/10.1016/s0735-1097(15)60970-6
Gandhi, Parul U., Shweta Motiwala, Arianna Belcher, Hanna Gaggin, Rory Weiner, Aaron Baggish, Mona Fiuzat, Hans-Peter Brunner-La Rocca, and James Januzzi. “ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION.” In Journal of the American College of Cardiology, 65:A970–A970. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60970-6.
Gandhi PU, Motiwala S, Belcher A, Gaggin H, Weiner R, Baggish A, et al. ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION. In: Journal of the American College of Cardiology. Elsevier BV; 2015. p. A970–A970.
Gandhi, Parul U., et al. “ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION.” Journal of the American College of Cardiology, vol. 65, no. 10, Elsevier BV, 2015, pp. A970–A970. Crossref, doi:10.1016/s0735-1097(15)60970-6.
Gandhi PU, Motiwala S, Belcher A, Gaggin H, Weiner R, Baggish A, Fiuzat M, Rocca H-PB-L, Januzzi J. ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION. Journal of the American College of Cardiology. Elsevier BV; 2015. p. A970–A970.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2015

Volume

65

Issue

10

Start / End Page

A970 / A970

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology